NCT03554902

Brief Summary

Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016. The objective of this study is to prospectively collect data of patients who underwent an endoscopic gastric tubulization, from last visit before procedure to 2 years after procedure. These data are usually collected during medical consultations and will enable the evaluation of weight loss, quality of life and comorbidities improvement, reproducibility and durability of the technique.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
26mo left

Started Jun 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jun 2018Jun 2028

First Submitted

Initial submission to the registry

May 16, 2018

Completed
23 days until next milestone

Study Start

First participant enrolled

June 8, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 13, 2018

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

10 years

First QC Date

May 16, 2018

Last Update Submit

April 29, 2025

Conditions

Keywords

Endoscopic gastric tubulizationWeight lossQuality of life

Outcome Measures

Primary Outcomes (3)

  • Change in weight loss

    Change in weight loss measured in kilograms.

    7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure

  • Change in excess weight loss

    Change in excess weight loss measured in percentage. Excess weight loss = (weight loss at time point / weight loss goal to reach a body mass index of 25 kg/m²) x 100

    7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure

  • Change in body mass index variation

    Change in body mass index variation measured in kg/m².

    7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure

Secondary Outcomes (9)

  • Number of patients with procedure-related adverse event

    7 days, 1 - 3 - 6 - 9 and 12 months after procedure

  • Comorbidities improvement

    7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure

  • Quality of life improvement

    3 - 12 - 18 and 24 months after procedure

  • Gastro-intestinal quality of life improvement

    3 - 12 - 18 and 24 months after procedure

  • Modification in the feeling of satiety

    1 - 3 - 6 - 12 - 18 and 24 months after procedure

  • +4 more secondary outcomes

Study Arms (1)

Endoscopic gastric tubulization

Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA).

Procedure: Endoscopic gastric tubulization

Interventions

Endoscopic gastric tubulization is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA).

Endoscopic gastric tubulization

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years old requiring a treatment for morbid obesity.

You may qualify if:

  • Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil

Strasbourg, 67091, France

RECRUITING

Related Publications (5)

  • Lopez-Nava G, Galvao MP, da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015 May;47(5):449-52. doi: 10.1055/s-0034-1390766. Epub 2014 Nov 7.

    PMID: 25380508BACKGROUND
  • Lopez-Nava G, Galvao MP, Bautista-Castano I, Jimenez-Banos A, Fernandez-Corbelle JP. Endoscopic Sleeve Gastroplasty: How I Do It? Obes Surg. 2015 Aug;25(8):1534-8. doi: 10.1007/s11695-015-1714-7.

    PMID: 26003549BACKGROUND
  • Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016 Feb;4(2):E222-7. doi: 10.1055/s-0041-110771. Epub 2016 Jan 15.

    PMID: 26878054BACKGROUND
  • Sharaiha RZ, Kedia P, Kumta N, DeFilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015 Feb;47(2):164-6. doi: 10.1055/s-0034-1390773. Epub 2014 Nov 7.

    PMID: 25380510BACKGROUND
  • Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013 Sep;78(3):530-5. doi: 10.1016/j.gie.2013.04.197. Epub 2013 May 24.

    PMID: 23711556BACKGROUND

MeSH Terms

Conditions

Obesity, MorbidWeight Loss

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Study Officials

  • Silvana Perretta, MD, PhD

    Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

    PRINCIPAL INVESTIGATOR
  • Michel Vix, MD

    Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2018

First Posted

June 13, 2018

Study Start

June 8, 2018

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations